CHARACTERIZATION OF BINDING-SITES FOR SPIDER TOXIN, [H-3] NSTX-3, IN THE RAT-BRAIN

被引:11
|
作者
INO, H
NAKADE, S
NIINOBE, M
IKENAKA, K
TESHIMA, T
WAKAMIYA, T
MATSUMOTO, T
SHIBA, T
KAWAI, N
MIKOSHIBA, K
机构
[1] OSAKA UNIV,FAC SCI,DEPT CHEM,TOYONAKA,OSAKA 560,JAPAN
[2] PROT RES FDN,INST PEPTIDE,MINOO,OSAKA,JAPAN
[3] TOKYO METROPOLITAN INST NEUROSCI,DEPT NEUROBIOL,FUCHU,TOKYO 183,JAPAN
[4] NATL INST BASIC BIOL,OKAZAKI,AICHI 444,JAPAN
关键词
Binding experiment; Glutamate receptor; Rat; Spider toxin; [!sup]3[!/sup]H]NSTX-3;
D O I
10.1016/0168-0102(90)90054-I
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A group of spider toxins (JSTX, NSTX, argiopin, argiotoxin etc.) share a basic common structure and have been reported to block strongly quisqualate- and kainate-sensitive glutamate responses in vertebrate and invertebrate nervous systems. They are presumed to be potent antagonists of both quisqualate and kainate receptors and may serve as useful tools for characterizing these receptors. We report here the synthesis of tritium-labeled NSTX-3 and the characterization of its binding sites in the rat brain. We found that high- and low-affinity binding sites exist in the cerebellum (Kd = 7.75 and 202 nM, Bmax = 0.37 and 5.54 pmol/mg protein, respectively). Synethetic NSTX analogs strongly inhibited [3H]NSTX-3 binding in the cerebellum (IC50 = 10-7-10-6 M), whereas competitive agonists of glutamate receptors (AMPA, quisqualate, NMDA, kainate, glutamate and aspartate) exhibited weak or no inhibitory effects. © 1990.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 50 条
  • [41] CHARACTERIZATION OF SPECIFIC BINDING-SITES FOR [H-3] (D)-N-ALLYLNORMETAZOCINE IN RAT-BRAIN MEMBRANES
    ITZHAK, Y
    HILLER, JM
    SIMON, EJ
    MOLECULAR PHARMACOLOGY, 1985, 27 (01) : 46 - 52
  • [42] IDENTIFICATION AND CHARACTERIZATION OF SPECIFIC BINDING-SITES OF [H-3] SPERMIDINE IN SYNAPTIC-MEMBRANES OF RAT-BRAIN
    YONEDA, Y
    OGITA, K
    ENOMOTO, R
    SUZUKI, T
    KITO, S
    BRAIN RESEARCH, 1991, 563 (1-2) : 17 - 27
  • [43] PHARMACOLOGICAL CHARACTERIZATION OF BINDING-SITES IDENTIFIED IN RAT-BRAIN FOLLOWING INVIVO ADMINISTRATION OF [H-3] SPIPERONE
    CHIVERS, J
    JENNER, P
    MARSDEN, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (03) : 467 - 478
  • [44] [H-3] RYANODINE BINDING-SITES IN RAT-BRAIN DEMONSTRATED BY MEMBRANE-BINDING AND AUTORADIOGRAPHY
    PADUA, RA
    WAN, WH
    NAGY, JI
    GEIGER, JD
    BRAIN RESEARCH, 1991, 542 (01) : 135 - 140
  • [45] [H-3]TRYPTAMINE BINDING-SITES ARE NOT IDENTICAL TO MONOAMINE-OXIDASE IN RAT-BRAIN
    PERRY, DC
    GRIMM, LJ
    KETTLER, KG
    KELLAR, KJ
    JOURNAL OF NEUROCHEMISTRY, 1988, 51 (05) : 1535 - 1540
  • [46] STEREOSPECIFIC BINDING-SITES FOR [H-3] NICOTINAMIDE ADENINE-DINUCLEOTIDE IN THE RAT-BRAIN
    SNELL, PH
    SNELL, CR
    RICHARDS, CD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (1-2) : 121 - 127
  • [47] NUCLEOTIDES MODULATE THE LOW AFFINITY BINDING-SITES FOR [H-3] GLIBENCLAMIDE IN THE RAT-BRAIN
    ZINI, S
    ZINI, R
    BENARI, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (02): : 701 - 708
  • [48] AUTORADIOGRAPHIC DISTRIBUTION OF NONDOPAMINERGIC BINDING-SITES LABELED [H-3] HALOPERIDOL IN RAT-BRAIN
    CONTRERAS, PC
    QUIRION, R
    GEHLERT, DR
    CONTRERAS, ML
    ODONOHUE, TL
    NEUROSCIENCE LETTERS, 1987, 75 (02) : 133 - 140
  • [49] DIFFERENT CHARACTERISTICS OF H-3 CALCIUM-ANTAGONIST BINDING-SITES IN THE RAT-BRAIN
    MATSUBAYASHI, H
    KITO, S
    MIYOSHI, R
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P84 - P84
  • [50] QUANTITATIVE LIGHT MICROSCOPIC LOCALIZATION OF [H-3] NALTRINDOLE BINDING-SITES IN THE RAT-BRAIN
    DROWER, EJ
    DORN, CR
    MARKOS, CS
    UNNERSTALL, JR
    RAFFERTY, MF
    CONTRERAS, PC
    BRAIN RESEARCH, 1993, 602 (01) : 138 - 142